Ostrow S S, Diggs C H, Sutherland J C, Gustafson J, Wiernik P H
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):929-33.
Lymphoma patients with a nodular pattern have a better prognosis than those with a diffuse pattern. Histologic evolution from nodular to diffuse may occur during the course of the disease in the same patient. This change in pattern may be of prognostic significance. We reviewed 56 patients with an initial diagnosis of nodular poorly differentiated lymphoma seen over a 12-year period (1966-1978). Thirty-five patients had biopsies after initial diagnosis, and 28 of the cases could be classified as nodular or diffuse. Eleven of the 56 cases evolved from a nodular to a diffuse pattern. Forty-four of the 56 patients achieved a complete remission and were evaluated for survival. The median survival (66+ months) for patients who have never relapsed is similar to that for patients who relapsed with a nodular pattern (70 months) and patients who relapsed with a diffuse pattern (73 months). Relapse with a nodular pattern occurred at a median of 27 months after initial diagnosis and relapse with a diffuse pattern (73 months). Relapse with a nodular pattern occurred at a median of 27 months after initial diagnosis and relapse with a diffuse pattern occurred at a median of 49 months. Although overall survival in patients relapsing with nodular or diffuse disease is similar, median survival from relapse with nodular disease is longer (32+ months) than median survival with diffuse disease (17 months) (P = 0.068).
具有结节型的淋巴瘤患者比弥漫型患者预后更好。在同一患者的疾病过程中可能会发生从结节型到弥漫型的组织学演变。这种类型的改变可能具有预后意义。我们回顾了在12年期间(1966 - 1978年)初诊为结节性低分化淋巴瘤的56例患者。35例患者在初诊后进行了活检,其中28例可分类为结节型或弥漫型。56例中有11例从结节型演变为弥漫型。56例患者中有44例实现了完全缓解并对生存情况进行了评估。从未复发患者的中位生存期(66 + 个月)与结节型复发患者(70个月)和弥漫型复发患者(73个月)相似。结节型复发发生在初诊后中位27个月,弥漫型复发发生在中位49个月。虽然结节型或弥漫型疾病复发患者的总生存期相似,但结节型疾病复发后的中位生存期(32 + 个月)比弥漫型疾病(17个月)更长(P = 0.068)。